News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
271,498 Results
Type
Article (14384)
Company Profile (282)
Press Release (256832)
Multimedia
Podcasts (53)
Webinars (9)
Section
Business (79598)
Career Advice (153)
Deals (13260)
Drug Delivery (35)
Drug Development (50510)
Employer Resources (31)
FDA (5747)
Job Trends (5144)
News (144573)
Policy (10041)
Tag
Academia (916)
Accelerated approval (3)
Adcomms (14)
Allergies (60)
Alliances (21759)
ALS (77)
Alzheimer's disease (881)
Antibody-drug conjugate (ADC) (125)
Approvals (5782)
Artificial intelligence (148)
Autoimmune disease (25)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (51)
Biotechnology (232)
Bladder cancer (65)
Brain cancer (27)
Breast cancer (199)
Cancer (1831)
Cardiovascular disease (138)
Career advice (134)
Career pathing (2)
CAR-T (142)
CDC (4)
Cell therapy (380)
Cervical cancer (9)
Clinical research (41646)
Collaboration (661)
Company closure (1)
Compensation (318)
Complete response letters (13)
COVID-19 (1047)
CRISPR (60)
C-suite (201)
Cystic fibrosis (85)
Data (2005)
Denatured (11)
Depression (41)
Diabetes (173)
Diagnostics (1317)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (96)
Drug pricing (32)
Drug shortages (3)
Duchenne muscular dystrophy (114)
Earnings (30333)
Editorial (19)
Employer branding (4)
Employer resources (29)
Events (49443)
Executive appointments (538)
FDA (6641)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (4)
Frontotemporal dementia (9)
Funding (602)
Gene editing (122)
Generative AI (10)
Gene therapy (310)
GLP-1 (407)
Government (1096)
Grass and pollen (2)
Guidances (76)
Healthcare (6602)
Huntington's disease (29)
IgA nephropathy (37)
Immunology and inflammation (107)
Immuno-oncology (4)
Indications (24)
Infectious disease (1118)
Inflammatory bowel disease (123)
Inflation Reduction Act (9)
Influenza (23)
Intellectual property (78)
Interviews (18)
IPO (7315)
IRA (11)
Job creations (864)
Job search strategy (127)
Kidney cancer (8)
Labor market (9)
Layoffs (220)
Leadership (3)
Legal (1392)
Liver cancer (34)
Lung cancer (255)
Lymphoma (134)
Machine learning (5)
Management (7)
Manufacturing (179)
MASH (72)
Medical device (2609)
Medtech (2610)
Mergers & acquisitions (6355)
Metabolic disorders (469)
Multiple sclerosis (63)
NASH (13)
Neurodegenerative disease (86)
Neuropsychiatric disorders (29)
Neuroscience (1380)
NextGen: Class of 2025 (2021)
Non-profit (855)
Now hiring (24)
Obesity (222)
Opinion (104)
Ovarian cancer (82)
Pain (52)
Pancreatic cancer (80)
Parkinson's disease (149)
Partnered (8)
Patents (163)
Patient recruitment (103)
Peanut (38)
People (25870)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14730)
Phase II (19374)
Phase III (12223)
Pipeline (1062)
Policy (61)
Postmarket research (852)
Preclinical (6247)
Press Release (30)
Prostate cancer (81)
Psychedelics (37)
Radiopharmaceuticals (219)
Rare diseases (348)
Real estate (1425)
Recruiting (12)
Regulatory (8805)
Reports (18)
Research institute (941)
Resumes & cover letters (17)
Rett syndrome (8)
RNA editing (9)
RSV (10)
Schizophrenia (69)
Series A (116)
Series B (75)
Service/supplier (1)
Sickle cell disease (48)
Special edition (13)
Spinal muscular atrophy (117)
Sponsored (13)
Startups (1981)
State (1)
Stomach cancer (4)
Supply chain (24)
Tariffs (14)
The Weekly (41)
Vaccines (237)
Venture capital (38)
Weight loss (114)
Women's health (16)
Worklife (2)
Date
Today (42)
Last 7 days (277)
Last 30 days (1398)
Last 365 days (18570)
2025 (9663)
2024 (20551)
2023 (22414)
2022 (26823)
2021 (27810)
2020 (23356)
2019 (16223)
2018 (11739)
2017 (13746)
2016 (11840)
2015 (14354)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (50)
Alaska (2)
Arizona (56)
Arkansas (5)
Asia (17557)
Australia (2974)
California (4647)
Canada (1307)
China (470)
Colorado (178)
Connecticut (172)
Delaware (133)
Europe (37725)
Florida (579)
Georgia (144)
Hawaii (1)
Idaho (16)
Illinois (278)
India (11)
Indiana (112)
Iowa (6)
Japan (115)
Kansas (65)
Kentucky (6)
Louisiana (4)
Maine (11)
Maryland (542)
Massachusetts (3729)
Michigan (85)
Minnesota (173)
Mississippi (2)
Missouri (25)
Montana (14)
Nebraska (4)
Nevada (20)
New Hampshire (14)
New Jersey (1142)
New Mexico (12)
New York (1243)
North Carolina (610)
North Dakota (6)
Northern California (2074)
Ohio (128)
Oklahoma (9)
Oregon (21)
Pennsylvania (868)
Puerto Rico (7)
Rhode Island (21)
South America (209)
South Carolina (6)
Southern California (1762)
Tennessee (29)
Texas (560)
United States (15826)
Utah (67)
Virginia (98)
Washington D.C. (36)
Washington State (399)
West Virginia (1)
Wisconsin (24)
271,498 Results for "eikon therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Funding
Eikon Adds Nearly $351M to Conquer Phase III Development in Melanoma
Eikon’s lead candidate, EIK1001, is being tested for advanced melanoma. The candidate is currently in late-stage development, which the biotech will fund using Wednesday’s series D raise.
February 26, 2025
·
1 min read
·
Tristan Manalac
Press Releases
Eikon Therapeutics to Share Clinical Data and Program Updates at the 2025 ASCO Annual Meeting
May 29, 2025
·
5 min read
Press Releases
Eikon Therapeutics Announces Nature Methods Publication Highlighting its Pioneering Oblique Line Scan Technology
February 19, 2025
·
4 min read
Press Releases
Eikon Therapeutics Secures $350.7 Million Series D to Advance Clinical-Stage Programs and Future Pipeline
February 26, 2025
·
3 min read
Biotech Bay
Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting
Eikon Therapeutics Announces Multiple Abstracts to be Presented at the American Society of Clinical Oncology (ASCO) Annual Meeting.
May 28, 2024
·
3 min read
Press Releases
Eikon Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 7, 2025
·
1 min read
Press Releases
Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Operating Officer
November 20, 2024
·
3 min read
Business
Eikon Therapeutics Announces the Election of Robert L. Huffines to its Board of Directors
Eikon Therapeutics, Inc. announced today the appointment of Robert (“Robbie”) L. Huffines as an independent director effective December 1, 2023.
December 4, 2023
·
3 min read
Biotech Bay
Eikon Therapeutics to Provide Corporate Updates at the 42nd Annual J.P. Morgan Healthcare Conference
Eikon Therapeutics, Inc., a pioneering biotechnology company that leverages advanced engineering to enhance drug discovery and development, today announced that the company will provide an overview of clinical and preclinical progress in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8th at 9:00 AM Pacific Time.
January 8, 2024
·
4 min read
Biotech Bay
Eikon Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Eikon Therapeutics, Inc. today announced that CEO and Board Chair, Roger M. Perlmutter, M.D., Ph.D., will provide a business update highlighting pipeline and clinical development progress in a presentation at the 42nd Annual J.P. Morgan Healthcare Conference on Monday, January 8, 2024 at 9:00 AM Pacific Standard Time.
December 18, 2023
·
1 min read
1 of 27,150
Next
